Clinical Trials Directory

Trials / Completed

CompletedNCT00469430

Study of Conservative Versus Surgical Treatment of Appendicitis

Randomized Study of Conservative Versus Surgical Treatment of Appendicitis; Analyses of Result and Economics

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
360 (actual)
Sponsor
Göteborg University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if antibiotic treatment of appendicitis is an option compared to surgery. The investigators' hypothesis is that a majority of patients with appendicitis can heal without surgery and that there are several advantages with antibiotic treatment related to time to recover, complications and economical aspects.

Detailed description

Appendicitis is a common disease; 1/1000 gets it every year. 7% will get appendicitis during their lifetime. Surgery, open or laparoscopic, is the traditional treatment. A number of these patients don´t have appendicitis when operated on and the operation is therefore unnecessarily performed. It is also a risk for complications after surgery; for instance wound infection, postoperative small bowel obstruction. In our study we will compare antibiotic as the only treatment with traditional surgical treatment. Patients with "suspected appendicitis" are randomized to either surgery or antibiotics according to their birth date. Patients in "the surgery group" are treated according to standard routines. Patients in "the antibiotic group" are treated with intravenous antibiotics for at least 24h - this regime can be prolonged if clinical recovery doesn´t occur - and submitted from hospital with oral antibiotics. If patients in the antibiotic group deteriorate during the hospital stay (suspicious perforation) they will be operated. Parameters that will be analyzed are: * primary healing in the antibiotic group * frequency of relapse in appendicitis in the antibiotic group * complications in both groups * economical analysis (hospital stay, sick leave time, time off work) in both groups

Conditions

Interventions

TypeNameDescription
DRUGcefotaxim and metronidazoliv administration for at least 24 h

Timeline

Start date
2006-05-01
Primary completion
2007-09-01
Completion
2008-10-01
First posted
2007-05-04
Last updated
2009-04-21

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT00469430. Inclusion in this directory is not an endorsement.